Latest news with #orthopaedic
Al Bawaba
5 days ago
- Health
- Al Bawaba
AFC Honors Aspetar's Key Contributions to Advancing Sports Medicine at 8th Medical Conference
Aspetar is a world leading specialised orthopaedic and sports medicine hospital, and the first of its kind in the Middle East. Since 2007, with a world expert team, the hospital has provided top-level comprehensive medical treatment to all athletes in a state-of-the-art facility that sets new standards internationally. In 2009, Aspetar was accredited as a 'FIFA Medical Centre of Excellence'. In 2013, Aspetar was adopted as a reference collaborator centre by the Gulf Countries Council (GCC) Health Ministers Council and 'IOC Research Centre for Prevention of Injury and Protection of Athlete Health' in 2014. In 2015, Aspetar has been recognised as the 'IHF Reference Centre for Athlete and Referee Health'. In 2017, Aspetar was awarded World Health Organization's Patient Safety Friendly Hospital-Level 3 designation. In 2018, Aspetar – Orthopaedic and Sports Medicine Hospital was officially awarded Diamond Level accreditation status by Accreditation Canada. This is the highest level of accreditation award possible under the program and awarded to highly committed and quality-oriented organizations that monitor outcomes, use evidence and best practice to improve services. Aspetar is now the first hospital in the State of Qatar to be awarded this coveted Diamond Level Status. Aspetar is a member–organisation of Aspire Zone Foundation, Qatar's innovative sports and healthy lifestyle destination.
Daily Mail
19-07-2025
- Health
- Daily Mail
MIDAS SHARE TIPS: Three stocks that could net healthy profits from the battle to slash NHS waiting lists
The NHS was once the envy of the world. No longer. Health Secretary Wes Streeting openly admits it is in crisis, with more than six million people on waiting lists and chaos predicted if hospital doctors walk out this week. However, plans are afoot to deliver change, with more choice for patients, better use of technology and investment in tip-top GP surgeries to offer everything from biopsies to help with depression. As the Government works on the small print, canny firms are already stepping in to offer solutions – and creating opportunities for investors to reap long-term rewards. Here are three that are giving the NHS a boost – and could do the same for your portfolio. One Health Group One Health Group was founded in 2004 by Derek Bickerstaff, an orthopaedic consultant who reckoned there must be a way to tackle waiting lists while continuing to provide patients with the free service offered by the NHS. His hunch was correct, and today One Health treats more than 17,000 people a year, providing consultations, operations and post-operative care for conditions ranging from dodgy hips to hernias. The company operates 40 community clinics across the Midlands and the North, and works with 130 NHS surgeons and anaesthetists. Patients wait two to four weeks for an initial consultation and undergo surgery, if needed, a few weeks later. Satisfaction levels are extremely high, and One Health is registered as a qualified alternative provider of care so the treatment is entirely free, just like the NHS. Bickerstaff's strategy is simple. He rents space in GP surgeries for his community clinics and space from private hospitals with spare capacity for operations. Agreements are also set up with surgeons and anaesthetists outside of their NHS obligations. Contracts are long-term and benefits are wide-ranging. GPs, hospitals and doctors receive extra income, patients are seen faster and NHS trusts can breathe easier. The business steers clear of affluent areas, where independent hospitals and NHS doctors can earn huge sums. Instead, it focuses on poorer parts of the country. Processes are smoother and more efficient because One Health does not deal with emergencies, is not involved in cancer or other complex conditions and has spent years developing its technology to the benefit of patients, doctors and suppliers. One Health joined the AQSE growth market in 2022 and moved up to Aim in March, raising cash along the way to fund its first surgical hub – a standalone site in Scunthorpe with an operating theatre and 12 beds. This should give a significant uplift to One Health profits. Today, the group gives about 70 per cent of gross revenues to hospitals in return for their space, facilities and nursing staff. The surgical hub will generate far higher profits at no cost to patients, and discussions are already under way for a second hub. NHS patients have a statutory right to choose their treatment provider, and increasing numbers are choosing One Health, which saw a 28 per cent increase in patients last year, generating a 23 per cent rise in revenues to £28.4 million with profits of £1.9 million and a dividend of 6.2p. One Health shares have had a strong run since joining Aim, and are now trading at £2.88. But brokers are optimistic about the business, suggesting shares could hit £3 or more over the next year or two. Buy and hold. Traded on: Aim Ticker: OHGR Contact: Optima Health The UK loses about £220 billion every year because people are taking days off sick or believe that they are too ill to work at all. Poor health is an epidemic, and the consequences spread far and wide. Hospitals are overstretched, depression is rife and economic growth is anaemic. Optima Health is the largest occupational health business in the country, working with some 2,000 employers, from NHS trusts, the police and HM Prisons to Bentley Motors, Ikea, investment banks and train operators. These organisations collectively employ five million people, almost 15 per cent of the nation's workforce, and Optima's job is to ensure they are fit and healthy so they can be fully productive. Police undergo fitness tests to check they are physically and mentally capable for the job. Factory workers are routinely assessed if they operate in noisy conditions or use vibrating tools. Even lollipop men and women have regular ear and eye tests to ensure they are capable of helping children cross the road. Under chief executive Jonathan Thomas, Optima also works with staff who are either on sick leave or think they may need to take time off. Aches and pains, such as back ache or dodgy knees, and mental health issues, such as stress or depression, are the biggest source of ill health. Optima employs more than 800 clinicians, including doctors, physiotherapists and mental health advisers, who identify ailments and help employees feel better and return to work. Thomas is expanding into new fields too, winning a seven-year, £210 million contract from the Armed Forces to conduct medical assessments on potential recruits for the Navy, the Army and the Air Force. Applicants will undergo rigorous checks to ensure they are physically and mentally fit to defend their country – from testing whether they can crawl through small spaces to seeing how they respond in high-stress situations. Optima has also spent ten years perfecting an online triage tool for bodily aches and pains, taking users through an eight-minute questionnaire to diagnose the next stage of treatment. Already in use by businesses across the country, the tool has now been taken up by the Mersey & West Lancashire Teaching Hospitals Trust, which runs hospitals and clinics across the North West. Discussions are under way with other NHS Trusts and further contracts are expected, as the tool can be used night and day, delivers more accurate results than face-to-face triage and cuts waiting lists dramatically, while ensuring people secure the right treatment. Results for the year to March included profits of £2.6 million. They are expected to more than double this year. Occupational health is a fragmented industry with thousands of small players. This presents plenty of opportunities for Optima. The workforce is changing too, growing older, larger and less healthy, which should bode well for Optima, making the shares a long-term buy at £1.94. Traded on: Aim Ticker: OPT Contact: Assura/PHP Crunch time is approaching for shareholders in GP-surgeries-to- private-hospital owner Assura. The company has been at the centre of a bidding war between UK-listed healthcare specialist PHP and US private equity giant, KKR, bidding through a company called Sana Bidco. Assura's board has recommended the PHP offer. Now shareholders must decide whether to follow their advice. They should, as the PHP deal is likely to deliver far greater long-term benefits. PHP owns about 500 healthcare centres offering everyday GP appointments as well as services from physiotherapy and weight management to biopsies and post-cancer care. A tie-up with Assura would create a group with more than 1,000 sites, easing the pressure on hospitals. A trading update from PHP showed it is forging ahead – a larger group would almost certainly do even better. PHP has a 29-year record of dividend growth, too, and boss Mark Davies has said the merged business should bolster shareholder payouts. Assura investors should back this offer.
Yahoo
15-07-2025
- Business
- Yahoo
Zimmer Biomet to acquire Monogram for $177m
Zimmer Biomet has signed a definitive agreement to acquire orthopaedic robotics company Monogram Technologies for an upfront cash payment of $4.04 per share, reflecting an equity value of around $177m and nearly $168m enterprise value. Common stockholders of Monogram are entitled to a non-tradeable contingent value right (CVR) that could yield up to $12.37 per share in cash, contingent upon meeting specific product development, regulatory, and revenue milestones by 2030. Both companies' boards of directors have granted unanimous approval for the proposed transaction. The acquisition is expected to bolster Zimmer Biomet's ROSA robotics platform with Monogram's semi-autonomous and fully autonomous robotic technologies. Monogram's 510(k)-cleared semi-autonomous knee arthroplasty robotic technology is set to be commercialised with Zimmer implants in early 2027. The closure of the transaction is said to pave the way for Zimmer Biomet to potentially become the first to provide a completely autonomous surgical robot. With the ROSA platform nearing 2,000 installations worldwide, Zimmer Biomet is investing in new products and software applications. These include ROSA Knee with OptimiZe and ROSA Posterior Hip, which is expected to launch by 2027. The proposed transaction will be funded through Zimmer Biomet's cash reserves and debt financing sources. The acquisition is subject to regulatory approvals and other customary closing conditions, as well as approval by Monogram stockholders. The merger is expected to close later this year. Morgan Stanley & Co is acting as the exclusive financial adviser to Zimmer Biomet, with Hogan Lovells US providing legal advice. Wells Fargo Securities and Duane Morris are serving as financial and legal advisers, respectively, to Monogram. Zimmer Biomet president, chairman and CEO Ivan Tornos said: "Upon closing, our customer-centric portfolio will consist of the most comprehensive and flexible technology ecosystem to support the varying preferences of a vast array of surgeons – now and into the future. 'With Monogram's proprietary technology, Zimmer Biomet has the potential to become the first company to deliver fully autonomous capabilities and redefine both the standard of care and the future of orthopaedic surgery." In April, Zimmer Biomet completed the acquisition of Paragon 28 for an enterprise value of approximately $1.2bn. "Zimmer Biomet to acquire Monogram for $177m" was originally created and published by Medical Device Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
07-07-2025
- Business
- Yahoo
Amotio secures £810k to advance orthopaedic revision surgery
Welsh startup Amotio has raised £810,000 ($1.1m) to advance its technology for improving outcomes during orthopaedic revision surgery. The company's first major pre-seed funding round was led by a £500,000 ($682,000) investment from the Development Bank of Wales, with additional backing from European investment firm NLC Health Ventures and Orthopaedic Research UK. Implant fixation takes the approach of uncemented fixation, where an implant is anchored to the bone, or cemented, where an implant is fixed using a compound made of Polymethyl Methacrylate (PMMA). However, research from the UK indicates that around 7% of hip, knee, and shoulder implants require replacement due to issues such as implant failure, infection, loosening, or bone fractures. Amotio worked with biomechanical engineers from University Medical Center Utrecht to develop a solution for removing bone cement during hip revision surgery. The technology uses advanced digital joint mapping, 3D printing, and precision tools. Starting with a patient's CT scan, the system allows surgeons to collaborate with Amotio to create the surgical plan, including a custom-made guide and a specialised device for safe bone cement removal. Through early-stage investment and non-dilutive funding, Amotio has now raised around £1.6m ($2.1m), which will support the company's ongoing R&D and eventually help it progress to pre-clinical testing and regulatory approval for the technology. Amotio's eventual expectation is to expand its technology for use in all major joint surgeries for patients in global markets including the US, Europe, and the Asia-Pacific. Amotio CEO Iestyn Foster commented: 'In current financial conditions it is extremely difficult as a medtech start-up to attract initial early stage investment, but with the support of our co-founder and investor NLC Health Ventures, specialist venture funds from ORUK, and the Development Bank of Wales, they have all understood the complex needs of our business and the impact our solution will make, along with our ambitions for future growth.' In the US, major joint replacement surgeries among those aged 50 and above are projected to reach five million by 2030. "Amotio secures £810k to advance orthopaedic revision surgery" was originally created and published by Medical Device Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio
Telegraph
28-06-2025
- Automotive
- Telegraph
Rishabh Pant's car blew up and he stared death in the face, says surgeon who saved him
'Rishabh Pant was extremely lucky to be alive – extremely lucky.' Dr Dinshaw Pardiwala, the orthopaedic surgeon who treated the Indian cricket superstar after his car crash, is in no doubt about his fortune. 'To be in an accident like this, where the car actually overturns and blows up, the risk of death is extremely high.' On December 30, 2022, flamboyant wicketkeeper Pant – who made history by scoring two centuries in one Test against England at Headingley – drove from Delhi to his home town of Roorkee. At 5:30am, Pant lost control of his car on the Delhi-Dehradun highway. His vehicle skidded for 200 metres before hitting the road divider. While the Mercedes burned, Pant's right knee twisted at 90 degrees. 'My time in this world is over,' Pant thought to himself, he later said. He was just 25 years old – a year older than James Dean when he suffered his fatal car crash. But Pant and two passers-by broke open a window to allow him to escape before the car set on fire. Pant was hospitalised with major injuries to his head, back and feet. After a week in local hospitals, Pant was airlifted to Mumbai. 'When he first came in, he had a dislocated right knee,' Pardiwala recalls. 'He also had an injury to his right ankle, lots of other minor injuries all over. He had a lot of skin loss, so his entire skin from the nape of the neck down to his knees was completely scraped off in the process of that accident. Then getting out of the car – that broken glass scraped off a lot of the skin and the flesh from his back.' If Pant's first great fortune was to be alive, his second was that he still had his right leg at all. Injuries so grievous he could not brush his teeth for weeks 'When your knee dislocates, and all the ligaments break, there's a high possibility of the nerve or the main blood vessel also being injured,' Pardiwala explains. 'If the blood vessel gets injured, you typically have about four to six hours to restore the blood supply. Otherwise, there's a risk of losing your limb. The fact that his blood vessel wasn't injured despite having a severe high-velocity knee dislocation was extremely lucky.' When he met Pardiwala in Mumbai, Pant's first question was: 'Am I ever going to be able to play again?' His mother's first question to Pardiwala was simply: 'Is he ever going to be able to walk again?' ' We had a lengthy discussion about the fact that these are grievous injuries – we would need to reconstruct the entire knee,' Pardiwala recalls. 'Once we reconstruct the entire knee, we're going to have to then work through a whole process of letting it heal, letting it recover, then get back the basic functions – the range, the strength and the stability.' On January 6, 2023, two days after he arrived in Mumbai, Pant was put under general anaesthetic. Over the next four hours, Pardiwala performed surgery on his right knee, reconstructing three ligaments and repairing tendons and meniscus. For several weeks after the surgery, Pant's movement in his upper body – the area which had been far less affected than his legs – remained so debilitated that he could not brush his teeth without assistance. 'He lost a lot of skin, and so he couldn't really move his hands. They were completely swollen. He couldn't really move either of his hands initially.' It was weeks until Pant could even grip a glass safely to drink water without assistance. For four months after the accident, Pant could only walk with crutches. 'Typically, when we reconstruct these patients they are happy just to get back to normal life,' Pardiwala explains. 'If they can walk and do some minimal amount of recreational sports, they're happy.' But Pant's sights were altogether higher. Pardiwala 'really didn't know' whether Pant could play for India again. 'I said: 'We can certainly make sure that he walks again. I'm going to try my best to make sure that we can get him back to playing again.' 'We didn't really want to offer him too much initially, but we did want to give him hope. So I said: 'We'll break it down into steps.' Step one, of course, has to be the surgery. 'When we discussed it just after the surgery, the way I told him is the fact you're alive, the fact that your limbs survived – that's two miracles down. If we get you back to competitive cricket, that's going to be a third miracle. Let's just hope for everything, and then take it a step at a time. 'His question then was: 'OK, assuming that we do manage to get there, how long is it going to be?' I said: 'Probably looking at 18 months to get back to competitive cricket.'' After surgery, Pant remained in hospital for another 24 days until he was discharged. He remained in Mumbai for a further three weeks, staying in a hotel near the hospital. Then, Pant moved into accommodation by the National Cricket Academy in Bangalore, by the M. Chinnaswamy Stadium. This would remain his home for most of 2023. Pant returned to the Academy gym virtually every day, doing two sessions with physiotherapists or strength and conditioning coaches. Initially, these sessions were two hours each; within weeks, at Pant's request, they extended to 3½ hours each. The regime was a combination of strenuous exercise in the gym and long sessions of aqua therapy in the swimming pool. The programme had three phases: restoring range of movement; strengthening muscles; and finally regaining balance and agility. 'His whole aim was 'Get me back to normalcy as fast as possible',' Pardiwala remembers. 'And we were trying to make sure that we were doing just the optimum, not too little, but not too much. 'His recovery was much faster than we had anticipated. He was like: 'Nothing is too much.' He pushed harder than normal people.' Pant defied prognosis by four months From the very first discussions that he had with Pardiwala in Mumbai, Pant made it clear that he intended not only to return to elite cricket, but also to regain his place behind the stumps. This aim made his recovery programme more onerous. 'As a wicketkeeper, you have to squat hundreds of times a day,' Pardiwala explains. 'So we needed to get that capability.' Pardiwala recalls a conversation between Ricky Ponting, who was then his head coach at Delhi Capitals, and Pant. Ponting suggested that Pant initially return as a specialist batsman alone. 'Rishabh turned around and said: 'No, there's no way that I'm getting back to elite-level cricket as just a batsman. I want to enjoy my keeping and so I'm not going to get back just as a batsman, I will get back when I can bat and when I can keep wicket too.'' Pardiwala had originally told Pant that the best scenario was to make a full return within 18 months. Yet he made his return in a warm-up within 14 months of the crash. In March 2024, 14 months and three weeks after the accident, Pant returned to professional cricket, in the Indian Premier League. Pant got an emotional standing ovation as he walked out to bat for the first time. Unassumingly, he regained his form from before the crash, averaging 40.5 in the 2024 IPL season and keeping wicket in every match, too. 'He was diving around like crazy,' Pardiwala recalls. When he made his Test return, against Bangladesh, Pant marked his comeback with a century. WELCOME BACK TO RED BALL CRICKET AFTER 21 LONG MONTHS, RISHABH PANT...!!! - A swashbuckling 34 ball fifty by Pant. — Mufaddal Vohra (@mufaddal_vohra) September 7, 2024 While Pant, now 27, is as ebullient on the field as before his crash, he is a subtly different person off the field now. 'He recognises the fact that he was extremely lucky to be alive,' Pardiwala says. 'He's so motivated as a cricketer. 'If you knew the Rishabh before this happened, he's a much more mature human being. He's very philosophical now. He appreciates life and everything that goes around it. That typically happens to anyone who's faced death in the face. Someone who's had a near-death experience often gets life into perspective.' Pant's enforced break could ultimately mean that he plays more for India. Shane Warne's year-long absence from international cricket, for very different reasons – he was banned for a year for taking a banned diuretic – lengthened his own career. 'I'm sure he's going to be fitter now because he's realising the importance of it. A lot of athletes become much better after a big surgery than ever before. 'The difference is fitness levels. They were never exposed to those kinds of high levels of fitness and rehabilitation; even if they were exposed to it, they didn't understand the importance of it. 'He always worked at his fitness, I'm sure, but I think he worked more at his skills initially, and probably a little less at the fitness part of it. But now he realises the importance of fitness. So he's working out and making sure that all aspects of his body are strengthened enough. I think that gives him then the confidence to do what he does on the field.' So much confidence, indeed, that Pant celebrated the first of his twin centuries at Headingley with a hand spring: the same celebration that he used to mark a century in the IPL last month. The pyrotechnics reflect one of Pant's childhood loves. Rishabh Pant reaching 100 in the Rishabh Pant way 🔥6️⃣ "This fella is BOX OFFICE." 🍿 — Sky Sports Cricket (@SkyCricket) June 21, 2025 'Rishabh trained as a gymnast – and so although he looks large, he is quite agile, and he does have a lot of flexibility,' says Pardiwala. 'And that's why he's been doing those somersaults of late. 'It's a well-practised and perfected move – unnecessary though!' But not to a man with Pant's sense of theatre.
